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Quantitative data on the onset and evolution of malar-
ia epidemics are scarce. We review case studies from
recent African Plasmodium falciparum epidemics (Kisii and
Gucha Districts, Kenya, 1999; Kayanza Province, Burundi,
2000–2001; Aweil East, southern Sudan, 2003; Gutten and
Damot Gale, Ethiopia, 2003–2004). We highlight possible
epidemic risk factors and review delays in epidemic detec-
tion and response (up to 20 weeks), essentially due to poor
case reporting and analysis or low use of public facilities.
Epidemics lasted 15–36 weeks, and patients’ age profiles
suggested departures from classical notions of epidemic
malaria everywhere but Burundi. Although emergency
interventions were mounted to expand inpatient and outpa-
tient treatment access, we believe their effects were less-
ened because of delays, insufficient evaluation of disease
burden, lack of evidence on how to increase treatment cov-
erage in emergencies, and use of ineffective drugs.
Plasmodium falciparum malaria epidemics were detect-ed in 41 African sites from 1997 through 2002 (1). A
total of 125 million persons are considered at risk for
malaria epidemics, with an estimated yearly death rate of
155,000 to 310,000 (2).
Research on malaria epidemics mostly concerns long-
range forecasting, early warning, and early detection
(improved understanding of the role of temperature, rain-
fall, and El Niño–Southern Oscillation events [3–6], devel-
opment of epidemic detection thresholds [7]). Malaria epi-
demics evolve rapidly and most often occur in remote,
underresourced settings without proper surveillance. Data
on their evolution may thus go unrecorded, which prevents
the development of evidence-based recommendations on
effective epidemic control.
Recently, Médecins Sans Frontières (MSF) intervened
in several P. falciparum malaria epidemics in remote or
conflict-affected sub-Saharan African settings. We present
case studies from these interventions (Kisii and Gucha
Districts, Kenya, 1999; Kayanza Province, Burundi,
2000–2001; Gutten and Damot Gale, Ethiopia, 2003–
2004; Aweil East County, southern Sudan, 2003). We also
describe the epidemics and possible factors that explain
their occurrence, review challenges encountered in their
detection and control, and make recommendations for epi-
demic prevention and control policies. This article reports
health facility–based morbidity and mortality data.
Findings on deaths in the community will be presented
elsewhere (manuscript in review).
Methods
We reviewed MSF program reports; unpublished
assessments (8–12); and available morbidity, mortality,
diagnostic, and treatment data from each of the 5 interven-
tions. We also consulted archives of the United Nations
humanitarian data clearinghouse (www.reliefweb.int) for
general situation reports for each epidemic period and
extracted meteorologic indexes to explore the possible
contribution of climate to epidemic onset (online
Appendix, available from http://www.cdc.gov/ncidod/
EID/vol12no10/06-0540_app.htm).
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Results
Description of Intervention Sites
Four interventions (Table 1) took place in highland
environments, where peaks and valleys create a complex,
climate-affected altitude gradient of malaria transmission
and age-acquired immunity. Kisii and Gucha Districts are
located in the southern highlands of Nyanza Province,
Kenya, and experience low year-round transmission, with
short, dramatic, and increasingly frequent outbreaks (16).
Before May 1999, the last recorded epidemic had taken
place from January through April 1998. The epidemic we
describe also affected 10 nearby districts (17).
In Burundi’s northern Kayanza Province, a 3-year time
series up to September 2000 showed constant monthly
caseloads of ≈10,000 outpatients/month. In 2000, MSF
operated 7 of the province’s 22 outpatient facilities. The
September 2000–May 2001 epidemic, the largest ever
recorded in Burundi, affected 9 of 16 provinces, and 3.5
million cases were reported (18).
The Ethiopian highlands experience 2 moderate trans-
mission seasons every year (after rains in March through
April and August through September). Epidemics occur in
5- to 8-year cycles; >1 million cases were recorded in 1998
(1). The 2003–2004 epidemic affected 15 million persons
in 3 federal regions (19).
Finally, malaria is considered endemic in low-altitude
Aweil East County (Bahr el Ghazal state, southern Sudan),
although no data are available. Most cases occur from July
through January after spring rains.
Possible Epidemic Determinants
Findings on possible epidemic determinants are sum-
marized in Table 1. Factors noted at all sites were drought
in preepidemic years followed by above-average rainfall in
the preepidemic months and elevated drug resistance.
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Individual sites also experienced temperature abnormali-
ties, land pattern changes, and high malnutrition rates.
Further detail on these findings is provided in the online
Appendix.
Epidemic Alert and Detection
No early warnings were issued. In Kisii, the alert came
from the media in epidemic week 5 (when the district hos-
pital was overwhelmed with malaria cases). MSF issued
alerts in Kayanza (doubling of fever cases in epidemic
week 2, early exhaustion of antimalarial stocks), Aweil
East (quadrupled inpatient and outpatient malaria after epi-
demic week 1), and Damot Gale (increased proportion of
P. falciparum–positive test results among children admit-
ted to feeding centers, Figure 1). No alert information was
found for Gutten.
Formal epidemic declaration was hampered by missing
data. Time series for historical comparisons were available
in Kisii (12 years) and Kayanza (3 years), where, howev-
er, authorities initially suspected a typhus outbreak, until
the 80% seroprevalence detected among febrile patients
(epidemic week 7) pointed to P. falciparum. In Aweil East,
comparison with the 2 past years was confounded by 1) a
change in diagnostic strategy (from presumptive in 2001 to
rapid test–based in 2002 and 2003) and 2) decreased
access to treatment in 2003 because of flooding.
In Ethiopia, a malaria-specific surveillance system
aimed for early outbreak detection at both the village (pos-
itivity >25% detected among slides collected by field
workers in the community was considered an outbreak and
theoretically led to village-level mass treatment and vector
control) and woreda or zone (where weekly reports from
health facilities were compiled) levels. A malaria epidem-
ic was declared in August 2003 (6–10 weeks after proba-
ble onset) by East Wollega Zone, including Gutten. Data
from this surveillance system were difficult to interpret.
Only some of the reports reached the zone bureau, with a
delay of 4 to 6 weeks. In Damot Gale, despite incomplete
reporting, a massive increase in caseload was evident at
the province level (6,500 from July through October 2003
vs. 1,233 from July through October 2002); however, by
early July (epidemic onset), only reports up to April were
available. Furthermore, clinics aggregated mass fever
treatment and outpatient data, causing artificial incidence
spikes when the former took place. Conversely, drug short-
ages in August gave a false impression of declining inci-
dence. MSF had only been present in Damot Gale since
April 2003 and only operated feeding centers.
Operational Response
Interventions occurred 3–20 weeks late (Table 2). In
Kisii and Gucha, numerous agencies, including Merlin,
African Medical and Research Foundation (AMREF),
Cooperative for Assistance and Relief Everywhere, Inc.
(CARE), World Vision, the Kenyan Army, and medical
staff of Kenyatta National Hospital supported health struc-
tures. Elsewhere, MSF was the sole external agency.
Everywhere, facilities were initially overwhelmed. In Kisii
Hospital, bed occupancy reached 300% in the first 3
weeks. Hospitalization capacity was 0.45 beds per 10,000
people in Gutten and 0.53 beds per 10,000 in Damot Gale,
where, in June and July 2003 (epidemic onset), the rate of
outpatient consultations per person per year was 0.03–0.09
(0.5–1.0 is expected in such settings if access is good)
(20). Although waived once epidemics were officially rec-
ognized, user fees were initially charged in Kenya,
Burundi, and Ethiopia. In Aweil East, non-MSF clinics had
run out of chloroquine 3 weeks into the outbreak.
All interventions included inpatient components with
blood transfusion. Conversion of existing MSF nutritional
structures enabled expansion of care in Aweil East and
Damot Gale. To reach isolated communities, mobile clin-
ics, consisting of teams of nurses or nursing assistants
working with simple treatment algorithms, were estab-
lished at each site. However, this intervention occurred late
(10 weeks late in Kisii and Gucha, 7 in Kayanza, 8 in
Aweil East, 13 in Gutten, and 27 in Damot Gale) and, apart
from in Kayanza, after the epidemic peak (Table 2).
Choice of location depended on results of a cross-section-
al prevalence survey (Kisii and Gucha), distance from the
nearest health center or proximity to swampy areas
(Kayanza), known gathering point and greatest distance to
the outpatient department (Aweil East), known gathering
point near existing health posts (Gutten), and village mor-
bidity/mortality surveillance results (Damot Gale).
Diagnosis was presumptive everywhere except Ethiopia,
where the P. falciparum–specific rapid diagnostic test
(RDT) Paracheck (Orchid Biomedical Systems, Verna,
Goa, India) was used systematically (Table 2). In Aweil
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Figure 1. Trends in inpatient malaria caseload and positivity among
malnourished children admitted to feeding centers in Damot Gale,
Ethiopia, 2003–2004. MSF, Médecins Sans Frontières.
East, mobile teams traveled on bicycle and canoe, spend-
ing 3–4 days in each location; because transporting
patients with severe cases was impossible, more experi-
enced teams carried injectable artemether and anticonvul-
sant drugs and treated 110 patients on a semi-inpatient
basis (no outcome was recorded for these patients). At
other sites, mobile clinics remained on site for 1 day and
provided an ambulance service. Mobile teams were pres-
ent in each targeted village for no more than 1–2 days a
week on average and as little as once a month in Kenya
and Damot Gale (Table 2). Mobile clinics treated 46,541
(9.3%) of 501,214 reported cases in Kayanza, 34,749
(68.3%) of 50,863 in Aweil East, 7,258 (19.4%) of 37,457
in Gutten, and 467 (2.8%) of 16,621 in Damot Gale (Table
3). In Damot Gale, active severe case finding was organ-
ized (no data available).
Artemisinin-based combination therapy (ACT) was
deployed in Aweil East and in mobile clinics in Kenya
(Table 2). Its use was not officially authorized in Burundi
and in Ethiopia, where empiric evidence of poor sulfadox-
ine-pyrimethamine efficacy, later confirmed by in vivo
studies (15), led clinicians to use quinine as first-line
treatment. To ensure adherence to the 7-day regimen,
high-risk patients were treated intrarectally under obser-
vation (Table 3).
Surveillance and Epidemic Evolution
In Burundi, Sudan, and Ethiopia, surveillance data were
analyzed weekly. In Kayanza, RDT testing was carried out
every 2–3 weeks among outpatients to monitor epidemic
trends. In Aweil East and Gutten, an automated surveil-
lance spreadsheet generated key indicators and graphs
(caseload, proportionate morbidity and mortality, case-
fatality, RDT confirmation of diagnosis).
The Kisii and Gucha epidemic followed a historical
pattern of short dramatic peaks (Figure 2). Kisii Hospital
records showed that, during the first 12 epidemic weeks,
2,669 (22.2%) of children <5 years of age in Kisii munic-
ipality (≈12,000) were hospitalized for malaria (Table 3).
The Kayanza epidemic lasted 36 weeks and roughly
followed a normal distribution (Figure 3). A total of
501,214 cases were reported, for a minimum attack rate of
86.5%.
In Aweil East, a peak was reached by epidemic week 2,
and a steady decline followed, which reflected percentage
of confirmed malaria cases among women who came to
the clinic for antenatal visits (Figure 4). Children <5 years
of age (assumed to be 20% of the population) experienced
attack rates of >41.2% (all malaria) and 1.1% (complicat-
ed).
In Ethiopia, the epidemic’s evolution can partly be
reconstructed by plotting available microscopy results
from the Gutten government clinic, which yields a normal
distribution (Figure 5), and percentage P. falciparum posi-
tivity among malnourished children admitted to feeding
centers in Damot Gale (Figure 1). Results showed a steady
rise from June, a plateau in August and September, and a
new peak in late November after heavy rains.
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Profile of Patients 
Among uncomplicated cases, the proportion of patients
<5 years of age exceeded the expected levels of 15% to
20% in southern Sudan and Ethiopia but not Kenya, where
only presumptive diagnosis was used (Table 3). Patients
<5 years made up half of all complicated cases in Kisii,
Gucha, Gutten, and Damot Gale and almost 80% in Aweil
East. Case-fatality rates were comparable across ages and
sites except Gutten (footnote, Table 3). Convenience sam-
ples of outpatients or household surveys suggested high P.
falciparum prevalences at or near caseload peaks (Table
3). Where MSF was involved in both outpatient and inpa-
tient care (Kayanza, Aweil East, and Gutten), comparable
proportions of patients were hospitalized (1.2%, 1.9%, and
1.4% respectively).
Discussion
In sub-Saharan Africa, malaria epidemics arise suddenly
in mostly remote, disadvantaged settings without effective
alert systems. Our case studies show that large-scale inter-
ventions can be organized in such epidemics, and that these
interventions can considerably increase diagnostic and
treatment output. Both preparedness and control, however,
were seriously deficient. Epidemic detection was late every-
where, and additional delays occurred before external inter-
vention to support overwhelmed local health structures.
Experiences in Kisii, Gucha, Kayanza, Gutten, and
Damot Gale probably reflect conditions in neighboring
regions affected by the corresponding epidemics, although
scarcity of published records makes comparisons difficult.
This analysis relies on programmatic data, the limitations
of which are apparent.
Epidemic Risk and Vulnerability Factors
Climate
Our analysis did not include controls (i.e., sites where
no epidemics occurred). Nevertheless, remotely sensed cli-
mate data suggest rainfall abnormalities during key preepi-
demic periods: relative drought in the 2 or 3 preepidemic
years (with the exception of Kayanza) and above-average
rainfall 1–2 months before epidemic onset. No consistent
temperature pattern emerged.
The full role of such abnormalities as epidemic deter-
minants is unclear. Furthermore, although remotely sensed
environmental variables provide relatively robust and
accurate estimates (21) and are becoming more publicly
accessible (22), they remain only proxies for ground-based
measurements. Nonetheless, we believe that our findings
implicate climate abnormalities to a varying extent in all 5
epidemics and support strengthened monitoring of climate
variables for early warning.
Other Factors
Land cover changes in Aweil East (flooding) and in
Kayanza (rice paddy creation) probably favored vector
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breeding. Malnutrition, displacement, and drug resistance
may not in themselves cause epidemics, but in our settings
these factors probably exacerbated the epidemics’ magni-
tude, duration, and case-fatality ratios. The effects of past
drought and malnutrition are difficult to extricate: they are
related causally, and either could result in impaired immu-
nity (respectively, through reduced exposure to infection
and nutrient deficiencies). 
To our knowledge, no entomologic data were collected
during any of these epidemics, which limits the strength of
our findings; changes in vector species or breeding habitats
could have had a major role, but these factors can only be
imputed from observed land pattern or climate alterations.
Future studies on malaria epidemics should include
detailed entomologic profiling, even during the epidemics.
In short, we believe that, given available evidence, to
predicate epidemic prevention activities solely on the basis
of individual risk factors (meteorologic or other) would be
imprudent. Instead, appropriate decision support systems
should be built that integrate all relevant data (e.g., envi-
ronmental variables, food security and nutritional status,
drug efficacy, health coverage, vector characteristics, pop-
ulation at risk) into a risk profile for each epidemic-prone
population, to be updated regularly; in such a scenario,
warning flags (23) resulting from detected environmental
anomalies or other risk factors would result in enhanced
surveillance activity and increased emergency prepared-
ness (e.g., stockpiling drugs, ensuring insecticides and
spray teams are in place), rather than leading directly to
control activities.
Difficulties in Detection
Even without early warning, detecting epidemics with-
in 2 weeks of onset should be possible (24), provided that
weekly reporting and analysis are complete and timely and
that caseload data reflect community incidence trends. In
most case studies described here, epidemics were detected
after substantial delay and by agencies other than local
authorities with unconventional methods, such as RDT
monitoring among malnourished children. An exception
was Aweil East, where weekly reporting and analysis took
place. Several formal definitions of a malaria epidemic
have been proposed. Most, like the C-Sum or Cullen meth-
ods (22), rely on comparison with past caseloads. These
methods cannot be effective unless surveillance is greatly
improved. Experience from the Highland Malaria Project
(HIMAL) (7) shows that meeting the requirements of epi-
demic early detection requires supplementing existing rou-
tine surveillance systems with networks of representative
sentinel health facilities, new data collection forms, proce-
dures for rapid exchange of data between different levels
of the health system, and tools for the collation, analysis,
and interpretation of incoming data. However, the apparent
success of HIMAL’s pilot early detection systems in
selected districts of Uganda and Kenya suggests that these
efforts are viable, given requisite resources and motivation
(J. Cox and T. Abeku, pers. comm.).
Free treatment and steady drug supplies probably
favored early detection in Aweil East. Conversely, in
Ethiopia, facility use was too low to reflect the magnitude
of the emergency, and irregular drug distributions con-
founded epidemiologic monitoring. User fee systems may
have long-term benefits, but cost barriers hamper treat-
ment access (25). In impoverished populations at risk for
malaria epidemics, a free care policy may encourage early
treatment seeking and thus facilitate early epidemic
detection and monitoring, in addition to minimizing
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Figure 2. Trends in outpatient malaria
caseload in Kisii Hospital outpatient
department, Kenya, 1995–1999. Data
for December 1997 are missing
because of a nursing staff strike. 
Figure 3. Trends in outpatient malaria caseload in Kayanza
Province, Burundi, 1999–2001. MSF, Médecins Sans Frontières.
deaths. Conversely, user fee systems may result in “silent”
public health disasters.
Intervention Strategies
Expansion of Access
By the time interventions were implemented, their
potential effects were reduced. Mobile clinics were
deployed to expand health access and detect severe cases.
Implementation of clinics understandably varied according
to local conditions, but apart from in Aweil East, probably
had limited impact. Mobile clinic programs should be
designed on the basis of clearly identified catchment areas
and set frequencies with which communities should be vis-
ited. Although various criteria were used in our case stud-
ies, we believe that actual access to healthcare should be a
key indicator for selecting target populations. Rapid meth-
ods to assess antimalarial treatment coverage thus need to
be developed. How frequently communities are visited
determines both the improvement in treatment coverage
and the probability of preventing progression to severe dis-
ease through prompt treatment, which is likely to increase
exponentially with frequency of mobile team visits; we
hypothesize that frequent visits to selected sites may be
more efficient than infrequent visits to a wider area. Impact
monitoring should be included in future mobile clinic
interventions to adjust their strategy as the situation
evolves, and they should be evaluated after the fact. More
generally, alternative modes of rapidly decentralizing care,
such as fixed temporary health posts or training of resident
community health workers (possibly equipped with arte-
sunate suppositories to treat severely ill patients), merit
further exploration. Where no clear indications exist that
local health structures can cope with a large malaria epi-
demic, mobile clinics or other temporary treatment pro-
grams should be implemented immediately.
Reduction of Case-fatality Ratio
Case-fatality ratio among patients with complicated
cases was lower than current best estimates of 10% (2) and
13% (26); however, whether all cases were severe depends
on the case definition used. Treatment of uncomplicated
cases relied on failing drugs everywhere but Sudan, and
sulfadoxine-pyrimethamine monotherapy was probably
counterproductive because the drug stimulates gametocy-
togenesis (27) and thus transmission. Ineffective drug use
in Burundi probably limited the effect on mortality; in
Ethiopia, quinine first-line administration proved challeng-
ing because of vomiting and required impractical patient
monitoring.
Effect on Public Health
Kayanza excluded, the increased proportion of children
<5 years of age among inpatients, as previously observed
in Kenya (28), suggests that children were more suscepti-
ble to symptomatic disease, which challenges classical
notions of unstable, epidemic malaria. In Aweil East, the
predominance of children is consistent with stable,
mesoendemic to hyperendemic transmission, and this situ-
ation is probably better characterized as a severe seasonal
outbreak.
Clinic-based attack rates approach 100% for all age
groups when extrapolated to the entire epidemic period
(Kayanza and Gutten) and are even more alarming among
children <5 years of age in Kisii. Even after overdiagnosis
from presumptive treatment is accounted for, these rates
are likely to be gross underestimates. The vast gap in treat-
ment coverage was evident in Aweil East, where large-
scale deployment of mobile clinics greatly increased
output, and in Ethiopia, where despite capturing only the
declining phase of the epidemic, uninterrupted provision
of free care with effective drugs resulted in far higher out-
patient and inpatient department attendance. The true com-
munity incidence in these epidemics is probably much
greater than represented by regular reporting systems and
higher than current estimates of 0.5 episodes of malaria per
Malaria Epidemics and Interventions, 1999–2004
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Figure 4. Trends in outpatient caseload and proportionate malaria
among pregnant women attending antenatal consultations in Aweil
East, southern Sudan, 2002–2003. MSF, Médecins Sans
Frontières.
Figure 5. Trends in outpatient malaria caseload and slide positivi-
ty in Gutten, Ethiopia, 2003–2004. MSF, Médecins Sans
Frontières.
person per epidemic (29). Only population-based studies
can yield realistic estimates of this incidence.
Conclusion
Malaria epidemics create daunting medical emergen-
cies. In addition to ongoing research on alert systems, much
greater donor investment is necessary to prevent and con-
trol them. All 4 countries in this study are moving to ACT
combinations for outpatient treatment, a major improve-
ment that is still insufficient unless 1) simple but valid sur-
veillance data are transmitted and analyzed on a weekly
basis, maximizing the chance of early epidemic detection,
and 2) treatment coverage of uncomplicated and complicat-
ed cases truly reflects community needs. Further research is
needed on methods to rapidly estimate needs (incidence)
and coverage and on strategies to efficiently expand treat-
ment access. Arguably, focusing resources only on how to
predict and respond to epidemics might lead policymakers
to overlook basic problems with access to effective treat-
ment and tools for prevention that are common to both epi-
demic and stable malaria settings and that probably merit
similar solutions. Donors and policymakers should thus
aim for a balanced approach: improved capacity for epi-
demic prediction and response is needed, but long-term
improvements in access to proper care and vector control
by all members of the community, even before epidemics
strike, must not be neglected, as they could be the most rel-
evant determinants of decreased epidemic severity.
Because malaria epidemics are difficult to predict and
multifactorial, setting up controlled studies to formally
demonstrate the benefit of any single intervention will be
difficult. Properly documenting the cost, feasibility, and
output of these interventions and measuring the true extent
of malaria epidemics are nevertheless crucial to inform the
choice of future prevention and control strategies and must
be included in the research agenda.
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